Sellas Life Sciences Group Inc share price logo

Sellas Life Sciences Group Inc

NASDAQ: SLS

Small Cap

$5.15

+0.28

(+5.75%)

as on

Sellas Life Sciences Group Inc Stock Performance

as on May 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.93
    $5.17
    downward going graph

    4.27%

    Downside

    0.39%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.36
    $6.14
    downward going graph

    73.59%

    Downside

    19.22%

    Upside

    downward going graph

Sellas Life Sciences Group Inc share price movements today

Previous Close
$4.87
Open
$4.95
Volume
4.1M
Day's Low - High
$4.93 - $5.17
52 Week Low - High
$1.36 - $6.14

Sellas Life Sciences Group Inc Historical Returns

1 Month Return
+ 7.51 %
3 Month Return
+ 30.56 %
1 Year Return
+ 183.14 %
3 Year Return
+ 189.88 %
5 Year Return
-37.8 %

Sellas Life Sciences Group Inc Stock Fundamentals & Key Indicators

Check Sellas Life Sciences Group Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$898.7M

EPS (TTM)

-0.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-66.88%

Sellas Life Sciences Group Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sellas Life Sciences Group Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$898.7M-37.8%NA0.00%
BUY$40.2B127.94%75.8512.55%
BUY$107.9B99.08%25.1832.94%
NA$33.1BNA120.445.37%
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Sellas Life Sciences Group Inc Stock including INR - Dollar returns

The Sellas Life Sciences Group Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Sellas Life Sciences Group Inc investment value today

Current value as on today

₹3,36,018

Returns

₹2,36,018

(+236.02%)

Returns from Sellas Life Sciences Group Inc Stock

₹1,99,419 (+199.42%)

Dollar Impact

₹36,599 (+36.6%)

Analyst Recommendation on Sellas Life Sciences Group Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Sellas Life Sciences Group Inc. Average target price of $10

Sellas Life Sciences Group Inc Share Price Target

Get share price movements and forecasts by analysts on Sellas Life Sciences Group Inc.

What analysts predicted

48.5%UPSIDE

Target Price

$10

Current Price

$5.15

Analyzed by

7 Analysts

Target

$10.00

Sellas Life Sciences Group Inc target price $10, a slight upside of 48.5% compared to current price of $5.15. According to 7 analysts rating.

Indian Investors' Interest in Sellas Life Sciences Group Inc Stock

Investment in Sellas Life Sciences Group Inc Shares on INDmoney has grown by 57.14% in the last 30 days, indicating increased investment activity.

Time period: to

Change:57.14% versus previous 30 day period

Search interest for Sellas Life Sciences Group Inc Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-2% versus previous 30 day period

Sellas Life Sciences Group Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-9
-8
-9
-7
-7
-6
-6
-6
-7
-8
EBITDA
-9
-8
-9
-7
-7
-16
-6
-6
0
-8
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-9
-8
-9
-7
-7
-6
-5
-6
-6
-7
Income Tax Expense
-9
-8
-9
-7
-
9
-
-
-
-
Net Income
-9
-8
-9
-7
-7
-6
-5
-6
-6
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Sellas Life Sciences Group Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
7
1
-
-
-
Gross Profit
0
-
-
-
0
7
0
-
-
-
Operating Income
-15
-15
-31
-20
-16
-25
-41
-37
-31
-28
EBITDA
-15
-23
-33
0
26
-18
-31
0
0
-28
Interest Expense
3
0
0
0
0
4
0
-
-
-
Depreciation
-
-
-
-
0
-
-
-
-
-
Income Before Tax
-17
-23
-29
-19
-16
-20
-41
-37
-30
-26
Income Tax Expense
0
0
-1
0
0
0
0
-37
-
-
Net Income
-23
-23
-27
-19
-16
-20
-41
-37
-30
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-881947.37%
-272.36%
-4130.10%
0.00%
0.00%
0.00%

Sellas Life Sciences Group Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-8
-9
-7
-7
-6
-5
-6
-6
-7
Operating Cash Flow
-4
-10
-9
-7
-7
-9
-7
-7
-4
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
3
26
0
19
0
23
4
26
32
Change in Cash
-1
15
-9
11
-7
14
-3
19
27

Sellas Life Sciences Group Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-23
-27
-19
-16
-20
-41
-37
-30
-26
Operating Cash Flow
-10
-30
-17
-10
-26
-23
-31
-35
-28
Investing Cash Flow
1
-
-4
-4
-4
-4
-5
-
-
Financing Cash Flow
5
23
19
38
12
24
22
46
86
Change in Cash
-3
-7
1
28
-13
-4
-14
11
57

Global Institutional Holdings in Sellas Life Sciences Group Inc

Funds
Holdings
State Street Corp
1.19%
Two Sigma Investments LLC
0.59%
Bank of New York Mellon Corp
0.13%
Everhart Financial Group, Inc.
0.26%
Dagco Inc
0.56%

Insights on Sellas Life Sciences Group Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SLS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, SLS stock has moved up by 200.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SLS has outperformed top 5 stocks with highest market-cap in its industry

About Sellas Life Sciences Group Inc

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
OrganisationSellas Life Sciences Group Inc
Headquarters7 Times Square, New York, NY, United States, 10036
IndustryBiotechnology
CEODr. Angelos M. Stergiou M.D., ScD h.c.
E-voting on sharesClick here to vote

Key Management of Sellas Life Sciences Group Inc

Name

Title

Dr. Angelos M. Stergiou M.D., ScD h.c.

Founder, President, CEO & Director

Mr. John Thomas Burns CPA

Senior VP & CFO

Dr. Dragan Cicic M.D., MBA

Senior VP & Chief Development Officer

Ms. Stacy E. Yeung

VP, General Counsel & Corporate Secretary

Mr. Andrew Elnatan

Senior VP of Regulatory Affairs, CMC & Quality

FAQs

What is Sellas Life Sciences Group Inc share price today?

Sellas Life Sciences Group Inc share price today is $5.15 as on at the close of the market. Sellas Life Sciences Group Inc share today touched a day high of $5.17 and a low of $4.93.

What is the 52 week high and 52 week low for Sellas Life Sciences Group Inc share?

Sellas Life Sciences Group Inc share touched a 52 week high of $6.14 on and a 52 week low of $1.36 on . Sellas Life Sciences Group Inc stock price today i.e. is closed at $5.15,which is 16.12% down from its 52 week high and 278.68% up from its 52 week low.

What is Sellas Life Sciences Group Inc's market capitalisation today?

Sellas Life Sciences Group Inc market capitalisation is $0.00T as on .

How to invest in Sellas Life Sciences Group Inc Stock (SLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sellas Life Sciences Group Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sellas Life Sciences Group Inc Shares that will get you 0.2913 shares as per Sellas Life Sciences Group Inc share price of $5.15 per share as on May 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Sellas Life Sciences Group Inc Stock (SLS) from India?

Indian investors can start investing in Sellas Life Sciences Group Inc (SLS) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Sellas Life Sciences Group Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Sellas Life Sciences Group Inc share’s latest price of $5.15 as on May 7, 2026 at 1:29 am IST, you will get 1.9417 shares of Sellas Life Sciences Group Inc. Learn more about fractional shares .

What are the returns that Sellas Life Sciences Group Inc has given to Indian investors in the last 5 years?

Sellas Life Sciences Group Inc stock has given -37.8% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?